BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11474744)

  • 21. Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.
    Singer C; Papapetropoulos S; Farronay O
    Pediatr Neurol; 2005 Sep; 33(3):220-2. PubMed ID: 16139741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using Botox to treat refractory voiding dysfunction in children: two case studies.
    Campigotto M
    Urol Nurs; 2009; 29(1):20-5, 46. PubMed ID: 19331271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 26. Botulinum toxin: basic science and clinical uses in otolaryngology.
    Blitzer A; Sulica L
    Laryngoscope; 2001 Feb; 111(2):218-26. PubMed ID: 11210864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 28. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M; Kirschner J; Herrmann J; Geth K; Korinthenberg R; Berweck S; Heinen F; Mall V
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin Type A. Indications and results].
    Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in botulinum toxin applications].
    Zaleski P
    Pol Merkur Lekarski; 1999 Sep; 7(39):134-7. PubMed ID: 10598494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 33. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
    Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E
    Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin in the treatment of dystonias--a hospital based study.
    Gupta M; Singh G; Khwaja G
    J Assoc Physicians India; 2003 May; 51():447-53. PubMed ID: 12974424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of childhood spasticity secondary to cerebral palsy using Botox.
    Gill C; Covington C; Padaliya B; Newman W; Pomeroy T; Charles PD
    Tenn Med; 2003 Nov; 96(11):511-3. PubMed ID: 14635360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin in ophthalmology.
    Dutton JJ; Fowler AM
    Surv Ophthalmol; 2007; 52(1):13-31. PubMed ID: 17212988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications and limitations for the use of botulinum toxin for the treatment of facial wrinkles.
    Sarrabayrouse MA
    Aesthetic Plast Surg; 2002; 26(4):233-8. PubMed ID: 12397444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of botulinum toxin in dentistry.
    Hoque A; McAndrew M
    N Y State Dent J; 2009 Nov; 75(6):52-5. PubMed ID: 20069790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.